Amgen has provided funding for the ADA’s Strategic Alliance Council, the Interactive Obesity Experience at the 2025 ADA Scientific Sessions, and they support our advocacy work around patient access to obesity medications to increase access to comprehensive obesity treatment and services across the continuum of care, including pharmacological medications.
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.